Appetite suppressing drug could be game-changer in obesity fight

Some 60% of Irish people are obese or overweight. Carrying extra weight increases the risk of many other illnesses, including cancer and cardiovascular problems.

Some 60% of Irish people are obese or overweight. Carrying extra weight increases the risk of many other illnesses, including cancer and cardiovascular problems.

A new appetite suppressant drug, described as “a great breakthrough” for weight loss, resulted in some people losing more than one-fifth of their body weight in an international trial.

The drug – semaglutide – has been hailed as a potential new weapon in the fight against obesity by a Cork-based expert in nutrition. 

You have reached your article limit. Already a subscriber? Sign in

Save €40 on an Annual Subscription.​

Continue reading within unlimited digital access and exclusive subscriber benefits.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited